Key result
Roux-en-Y gastric bypass in severely obese Korean patients with type 2 diabetes resulted in 55% diabetes remission and 21.3% mean weight loss at 2 years.
Why the study?
Does Roux-en-Y gastric bypass improve metabolic parameters and diabetes remission in severely obese Korean patients with type 2 diabetes?
Cohort (n=33)
Does Roux-en-Y gastric bypass improve metabolic parameters and diabetes remission in severely obese Korean patients with type 2 diabetes?
Roux-en-Y gastric bypass in severely obese Korean patients with type 2 diabetes provides sustained reductions in visceral and intramuscular fat and high rates of diabetes remission, though nutritional deficiencies require monitoring.
RYGB was associated with diabetes remission in obese Korean patients; extends evidence to Asian cohorts but leaves open need for RCTs.
AIMS/INTRODUCTION: Little is known about the long-term effects of Roux-en-Y gastric bypass (RYGB) in severely obese Asian individuals. METHODS AND MATERIALS: A total of 33 severely obese patients with type 2 diabetes underwent RYGB. All patients were followed up for 2 years. Visceral and abdominal subcutaneous fat areas were assessed using computed tomography (CT) before, and 12 and 24 months after RYGB. The muscle attenuation (MA) of paraspinous muscles observed by CT were used as indices of intramuscular fat. RESULTS: The mean percentage weight loss was 22.2 ± 5.3% at 12 months, and 21.3 ± 5.1% at 24 months after surgery. Compared with the baseline values, the visceral fat area was 53.6 ± 17.1% lower 24 months after surgery, and the abdominal subcutaneous fat area was 32.7 ± 16.1% lower 24 months after surgery. The MA increased from 48.7 ± 10.0 at baseline to 52.2 ± 8.9 (P = 0.009) 12 months after surgery. The MA after the first 12 months maintained changes until 24 months. Triglycerides and free fatty acids were reduced after surgery, whereas the high-density lipoprotein cholesterol levels were increased significantly after surgery. At the last follow-up visit, 18 patients (55%) had diabetes remission. The percentage of iron and vitamin D deficiency was 30% and 52%, respectively. CONCLUSIONS: We found that patients subjected to RYGB had significant sustained reductions in visceral and intramuscular fat. There were durable improvements in the cardiometabolic abnormalities without any significant comorbidities. However, there were mild nutritional deficiencies in these patients despite daily supplementation with multivitamins and minerals.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2013) conducted a cohort in Severe obesity with type 2 diabetes (n=33). Roux-en-Y gastric bypass (RYGB) vs. Baseline was evaluated on Diabetes remission at 2 years. Roux-en-Y gastric bypass in severely obese Korean patients with type 2 diabetes resulted in 55% diabetes remission and 21.3% mean weight loss at 2 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: